163 related articles for article (PubMed ID: 22797826)
1. B ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites.
Cui S; Ba M; Tang Y; Liu J; Wu Y; Wang B; Zhang X; Tang H; Zhong S
Oncol Rep; 2012 Oct; 28(4):1325-31. PubMed ID: 22797826
[TBL] [Abstract][Full Text] [Related]
2. Multivariate comparison of B-ultrasound guided and laparoscopic continuous circulatory hyperthermic intraperitoneal perfusion chemotherapy for malignant ascites.
Ba MC; Long H; Cui SZ; Tang YQ; Wu YB; Zhang XL; Tang HS; Bai SX
Surg Endosc; 2013 Aug; 27(8):2735-43. PubMed ID: 23392978
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites.
Ba MC; Cui SZ; Lin SQ; Tang YQ; Wu YB; Wang B; Zhang XL
World J Gastroenterol; 2010 Apr; 16(15):1901-7. PubMed ID: 20397270
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites.
Garofalo A; Valle M; Garcia J; Sugarbaker PH
Eur J Surg Oncol; 2006 Aug; 32(6):682-5. PubMed ID: 16631341
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: A multi-institutional retrospective analysis in 52 patients.
Valle M; Van der Speeten K; Garofalo A
J Surg Oncol; 2009 Sep; 100(4):331-4. PubMed ID: 19697441
[TBL] [Abstract][Full Text] [Related]
7. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
Cavaliere F; Di Filippo F; Botti C; Cosimelli M; Giannarelli D; Aloe L; Arcuri E; Aromatario C; Consolo S; Callopoli A; Laurenzi L; Tedesco M; Di Angelo P; Giunta S; Cavaliere R
Eur J Surg Oncol; 2000 Aug; 26(5):486-91. PubMed ID: 11016471
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
Loggie BW; Fleming RA; McQuellon RP; Russell GB; Geisinger KR
Am Surg; 2000 Jun; 66(6):561-8. PubMed ID: 10888132
[TBL] [Abstract][Full Text] [Related]
10. Treatment of malignant ascites with a combination of chemotherapy drugs and intraperitoneal perfusion of verapamil.
Jia W; Zhu Z; Zhang T; Fan G; Fan P; Liu Y; Duan Q
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1585-90. PubMed ID: 23589316
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis.
Kunisaki C; Shimada H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Takahashi M
Hepatogastroenterology; 2006; 53(69):473-8. PubMed ID: 16795995
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.
Facchiano E; Scaringi S; Kianmanesh R; Sabate JM; Castel B; Flamant Y; Coffin B; Msika S
Eur J Surg Oncol; 2008 Feb; 34(2):154-8. PubMed ID: 17640844
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of regional chemotherapy using the hypoxic abdominal perfusion technique in advanced abdominal carcinoma. 5-FU pharmacokinetics, complications and outcome.
Pohlen U; Rieger H; Kunick-Pohlen S; Berger G; Buhr HJ
Anticancer Res; 2007; 27(1B):667-74. PubMed ID: 17348458
[TBL] [Abstract][Full Text] [Related]
14. [Laparoscopic intraperitoneal hyperthermic perfusion in palliation of malignant ascites. Case report].
Graziosi L; Bugiantella W; Cavazzoni E; Donini A
G Chir; 2009 May; 30(5):237-9. PubMed ID: 19505418
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center.
Yang XJ; Li Y; Yonemura Y
J Surg Oncol; 2010 May; 101(6):457-64. PubMed ID: 20401915
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
18. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Glockzin G; Renner P; Popp FC; Dahlke MH; von Breitenbuch P; Schlitt HJ; Piso P
Ann Surg Oncol; 2011 Apr; 18(4):1052-9. PubMed ID: 21046262
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic abdominal stop-flow perfusion in the treatment of advanced pancreatic cancer: a phase II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Caterino GP; Di Giuro G; Amicucci G
Eur J Surg Oncol; 2007 Feb; 33(1):72-8. PubMed ID: 17166688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]